Secondary Logo

Published Ahead-of-Print - Last Updated: November 14, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only



PDF Only


Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Song, Michael M.; Makena, Monish R.; Hindle, Ashly; More

Anti-Cancer Drugs. ., Post Author Corrections: September 27, 2018

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide

Apostolatos, André H.; Apostolatos, Christopher A.; Ratnayake, Wishrawana S.; More

Anti-Cancer Drugs. ., Post Author Corrections: September 10, 2018


PDF Only


Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

Onesti, Concetta E.; Iacono, Daniela; Angelini, Silvia; More

Anti-Cancer Drugs. ., Post Author Corrections: November 14, 2018


PDF Only


Show: